Literature DB >> 18005683

Type III secretion effectors of the IpaH family are E3 ubiquitin ligases.

John R Rohde1, Ashton Breitkreutz, Alexandre Chenal, Philippe J Sansonetti, Claude Parsot.   

Abstract

Many bacteria pathogenic for plants or animals, including Shigella spp., which is responsible for shigellosis in humans, use a type III secretion apparatus to inject effector proteins into host cells. Effectors alter cell signaling and host responses induced upon infection; however, their precise biochemical activities have been elucidated in very few cases. Utilizing Saccharomyces cerevisiae as a surrogate host, we show that the Shigella effector IpaH9.8 interrupts pheromone response signaling by promoting the proteasome-dependent destruction of the MAPKK Ste7. In vitro, IpaH9.8 displayed ubiquitin ligase activity toward ubiquitin and Ste7. Replacement of a Cys residue that is invariant among IpaH homologs of plant and animal pathogens abolished the ubiquitin ligase activity of IpaH9.8. We also present evidence that the IpaH homolog SspH1 from Salmonella enterica can ubiquitinate ubiquitin and PKN1, a previously identified SspH1 interaction partner. This study assigns a function for IpaH family members as E3 ubiquitin ligases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18005683     DOI: 10.1016/j.chom.2007.02.002

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  125 in total

1.  Ubiquitin and ubiquitin-modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin, ExoU.

Authors:  David M Anderson; Katherine M Schmalzer; Hiromi Sato; Monika Casey; Scott S Terhune; Arthur L Haas; Jimmy B Feix; Dara W Frank
Journal:  Mol Microbiol       Date:  2011-11-21       Impact factor: 3.501

2.  Conserved structural mechanisms for autoinhibition in IpaH ubiquitin ligases.

Authors:  Yang-Chieh Chou; Alexander F A Keszei; John R Rohde; Mike Tyers; Frank Sicheri
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

Review 3.  "Without Ub I am nothing": NEMO as a multifunctional player in ubiquitin-mediated control of NF-kappaB activation.

Authors:  Jérémie Gautheron; Gilles Courtois
Journal:  Cell Mol Life Sci       Date:  2010-05-26       Impact factor: 9.261

Review 4.  Exploitation of the ubiquitin system by invading bacteria.

Authors:  Olivia Steele-Mortimer
Journal:  Traffic       Date:  2010-11-24       Impact factor: 6.215

5.  A bacterial E3 ubiquitin ligase targets a host protein kinase to disrupt plant immunity.

Authors:  Tracy R Rosebrock; Lirong Zeng; Jennifer J Brady; Robert B Abramovitch; Fangming Xiao; Gregory B Martin
Journal:  Nature       Date:  2007-07-19       Impact factor: 49.962

Review 6.  Targeting of immune signalling networks by bacterial pathogens.

Authors:  Igor E Brodsky; Ruslan Medzhitov
Journal:  Nat Cell Biol       Date:  2009-05       Impact factor: 28.824

Review 7.  Symbiotic use of pathogenic strategies: rhizobial protein secretion systems.

Authors:  William J Deakin; William J Broughton
Journal:  Nat Rev Microbiol       Date:  2009-03-09       Impact factor: 60.633

8.  A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response.

Authors:  Hiroshi Ashida; Minsoo Kim; Marc Schmidt-Supprian; Averil Ma; Michinaga Ogawa; Chihiro Sasakawa
Journal:  Nat Cell Biol       Date:  2009-12-13       Impact factor: 28.824

9.  Structure of the Shigella T3SS effector IpaH defines a new class of E3 ubiquitin ligases.

Authors:  Alexander U Singer; John R Rohde; Robert Lam; Tatiana Skarina; Olga Kagan; Rosa Dileo; Nickolay Y Chirgadze; Marianne E Cuff; Andrzej Joachimiak; Mike Tyers; Philippe J Sansonetti; Claude Parsot; Alexei Savchenko
Journal:  Nat Struct Mol Biol       Date:  2008-11-09       Impact factor: 15.369

Review 10.  Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion.

Authors:  Gunnar N Schroeder; Hubert Hilbi
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.